INTERNATIONAL PATENT: RENAGADE THERAPEUTICS MANAGEMENT INC. FILES APPLICATION FOR "LIPID NANOPARTICLES COMPRISING CODING RNA MOLECULES FOR USE IN GENE EDITING AND AS VACCINES AND THERAPEUTIC AGENTS"

GENEVA, Aug. 26 -- RENAGADE THERAPEUTICS MANAGEMENT INC. (640 Memorial Drive, Suite 2300Cambridge, Massachusetts 02139) filed a patent application (PCT/US2025/015411) for "LIPID NANOPARTICLES COMPRISING CODING RNA MOLECULES FOR USE IN GENE EDITING AND AS VACCINES AND THERAPEUTIC AGENTS" on Feb 11, 2025. With publication no. WO/2025/174765, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JAYARAMAN, Muthusamy (c/o Renagade Therapeutics Management Inc.640 Memorial Drive, Suite 2300Cambridge, Massachusetts 02139), SANKARAN, G...